# Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome

> **NCT01178151** · PHASE2 · WITHDRAWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)**

## Conditions studied

- Peutz-Jeghers Syndrome
- Neoplastic Processes
- Neoplasm Metastasis

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01178151
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients
- **Last updated:** 2015-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01178151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01178151, "Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01178151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*